Literature DB >> 19504123

Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells.

Daniella Pfeifer1, Asa Wallin, Birgitta Holmlund, Xiao-Feng Sun.   

Abstract

PURPOSE: To study expression of proteins previously connected to radiotherapy response in rectal cancer patients, namely, p53, TAp73, DeltaNp73, survivin and PRL-3, after irradiation in colon cancer cells to gain standing ground for further studies of pathways and mechanisms.
METHODS: Three colon cancer cell lines (KM12C, KM12SM and KM12L4a) with one origin were radiated with gamma-radiation. Radiosensitivity was determined with cell cycle, survival fraction at 5 Gy (SF5) and apoptosis analysis and protein expression by Western blot.
RESULTS: Following irradiation, KM12C showed no cell cycle arrest, and low SF5 and apoptosis, whilst KM12L4a showed high SF5 and apoptosis. KM12SM had moderate radiosensitivity. After irradiation, the anti-apoptotic DeltaNp73 and mitosis-factor PRL-3 increased in KM12C and the radioresistance factor survivin increased in KM12L4a.
CONCLUSIONS: The cell lines seem to have evolved different protein patterns regarding the studied proteins and partly therefore developed different resistance mechanisms, less apoptosis for KM12C and continued proliferation for KM12L4a, after gamma-irradiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504123     DOI: 10.1007/s00432-009-0606-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  44 in total

1.  Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.

Authors:  T Okamoto; H Izumi; T Imamura; H Takano; T Ise; T Uchiumi; M Kuwano; K Kohno
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

2.  p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.

Authors:  Natalia N Kartasheva; Ana Contente; Claudia Lenz-Stöppler; Judith Roth; Matthias Dobbelstein
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

3.  Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy.

Authors:  Daniella Pfeifer; Jingfang Gao; Gunnar Adell; Xiao-Feng Sun
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-05       Impact factor: 7.038

4.  PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

Authors:  Haihe Wang; Samantha Yiling Quah; Jing Ming Dong; Edward Manser; Jing Ping Tang; Qi Zeng
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

Review 5.  Survivin as a target for new anticancer interventions.

Authors:  Nadia Zaffaroni; Marzia Pennati; Maria Grazia Daidone
Journal:  J Cell Mol Med       Date:  2005 Apr-Jun       Impact factor: 5.310

6.  A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors:  C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.

Authors:  Yoshiyuki Suzuki; Kuniyuki Oka; Daisaku Yoshida; Katsuyuki Shirai; Tatsuya Ohno; Shingo Kato; Hirohiko Tsujii; Takashi Nakano
Journal:  Gynecol Oncol       Date:  2006-12-01       Impact factor: 5.482

Review 8.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

9.  Change of conformation of the DNA-binding domain of p53 is the only key element for binding of and interference with p73.

Authors:  Karim Bensaad; Morgane Le Bras; Keziban Unsal; Sabrina Strano; Giovanni Blandino; Osamu Tominaga; Dany Rouillard; Thierry Soussi
Journal:  J Biol Chem       Date:  2003-01-07       Impact factor: 5.157

10.  Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

Authors:  T J Grob; U Novak; C Maisse; D Barcaroli; A U Lüthi; F Pirnia; B Hügli; H U Graber; V De Laurenzi; M F Fey; G Melino; A Tobler
Journal:  Cell Death Differ       Date:  2001-12       Impact factor: 15.828

View more
  11 in total

1.  Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.

Authors:  B Greve; F Sheikh-Mounessi; B Kemper; I Ernst; M Götte; H T Eich
Journal:  Strahlenther Onkol       Date:  2012-10-10       Impact factor: 3.621

2.  Survivin expression can predict the effect of chemoradiotherapy for advanced lower rectal cancer.

Authors:  Chie Takasu; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Hirohiko Sato; Masanori Nishioka; Shinya Morimoto; Kozo Yoshikawa; Tomohiko Miyatani; Hideya Kashihara; Tohru Utsunomiya; Hisanori Uehara
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

3.  Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy.

Authors:  Zhi-Yong Zhang; Hong Zhang; Gunnar Adell; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2011-03-01       Impact factor: 4.430

Review 4.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

5.  WRAP53 is an independent prognostic factor in rectal cancer- a study of Swedish clinical trial of preoperative radiotherapy in rectal cancer patients.

Authors:  Hong Zhang; Da-Wei Wang; Gunnar Adell; Xiao-Feng Sun
Journal:  BMC Cancer       Date:  2012-07-17       Impact factor: 4.430

6.  Retroviral integration mutagenesis in mice and comparative analysis in human AML identify reduced PTP4A3 expression as a prognostic indicator.

Authors:  Renée Beekman; Marijke Valkhof; Stefan J Erkeland; Erdogan Taskesen; Veronika Rockova; Justine K Peeters; Peter J M Valk; Bob Löwenberg; Ivo P Touw
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

Review 7.  Function, clinical application, and strategies of Pre-mRNA splicing in cancer.

Authors:  Cuixia Di; Qianjing Zhang; Yuhong Chen; Yupei Wang; Xuetian Zhang; Yang Liu; Chao Sun; Hong Zhang; Jörg D Hoheisel
Journal:  Cell Death Differ       Date:  2018-11-21       Impact factor: 15.828

8.  Lithium chloride increases sensitivity to photon irradiation treatment in primary mesenchymal colon cancer cells.

Authors:  Francesca Cammarota; Andrea Conte; Antonietta Aversano; Paolo Muto; Gianluca Ametrano; Patrizia Riccio; Mimmo Turano; Valeria Valente; Paolo Delrio; Paola Izzo; Giovanna Maria Pierantoni; Marina De Rosa
Journal:  Mol Med Rep       Date:  2020-01-21       Impact factor: 2.952

9.  AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.

Authors:  S Gnosa; H Zhang; V P Brodin; J Carstensen; G Adell; X-F Sun
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

Review 10.  Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates.

Authors:  Silvia Belluti; Giovanna Rigillo; Carol Imbriano
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.